| 0 |
APPLICATION SITE ECZEMA |
4 |
0.0460 |
| 1 |
APPLICATION SITE NODULE |
2 |
0.0146 |
| 2 |
APPLICATION SITE INFLAMMATION |
5 |
0.0036 |
| 3 |
APPLICATION SITE DERMATITIS |
3 |
0.0032 |
| 4 |
APPLICATION SITE PUSTULES |
1 |
0.0027 |
| 5 |
APPLICATION SITE PAIN |
46 |
0.0021 |
| 6 |
APPLICATION SITE DISCOLOURATION |
8 |
0.0020 |
| 7 |
MOLLUSCUM CONTAGIOSUM |
1 |
0.0019 |
| 8 |
APPLICATION SITE SCAB |
4 |
0.0019 |
| 9 |
APPLICATION SITE EXFOLIATION |
6 |
0.0015 |
| 10 |
APPLICATION SITE VESICLES |
9 |
0.0014 |
| 11 |
APPLICATION SITE ERYTHEMA |
31 |
0.0012 |
| 12 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 13 |
APPLICATION SITE DISCHARGE |
1 |
0.0009 |
| 14 |
APPLICATION SITE HYPERSENSITIVITY |
1 |
0.0008 |
| 15 |
APPLICATION SITE SWELLING |
4 |
0.0008 |
| 16 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 17 |
APPLICATION SITE IRRITATION |
8 |
0.0006 |
| 18 |
APPLICATION SITE BURN |
3 |
0.0006 |
| 19 |
APPLICATION SITE RASH |
8 |
0.0006 |
| 20 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
| 21 |
APPLICATION SITE PRURITUS |
12 |
0.0005 |
| 22 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 23 |
SKIN EROSION |
1 |
0.0003 |
| 24 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
| 25 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 26 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 27 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 28 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 29 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 30 |
SKIN LESION |
1 |
0.0000 |
| 31 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 32 |
RASH MACULAR |
1 |
0.0000 |
| 33 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 34 |
POLLAKIURIA |
1 |
0.0000 |
| 35 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 36 |
RASH PRURITIC |
1 |
0.0000 |
| 37 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 38 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 39 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 40 |
RASH |
1 |
0.0000 |